Semler Scientific Inc. (NASDAQ:SMLR) Receives $74.25 Average Target Price from Analysts

Semler Scientific Inc. (NASDAQ:SMLR) has received an average recommendation of “Moderate Buy” from the five research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target price among brokers that have covered the stock in the last year is $74.25.

Several research analysts have commented on the company. Weiss Ratings reissued a “hold (c)” rating on shares of Semler Scientific in a research report on Wednesday, October 8th. Maxim Group dropped their target price on Semler Scientific from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Friday, September 19th. Cantor Fitzgerald cut their price target on Semler Scientific from $61.00 to $60.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Finally, Benchmark cut their price target on Semler Scientific from $101.00 to $86.00 and set a “buy” rating on the stock in a research note on Tuesday, September 23rd.

Semler Scientific Trading Down 5.3%

NASDAQ:SMLR opened at $24.61 on Tuesday. The business’s 50-day moving average is $28.27 and its two-hundred day moving average is $33.79. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.60 and a quick ratio of 0.58. Semler Scientific has a 12 month low of $21.84 and a 12 month high of $81.56. The firm has a market capitalization of $372.60 million, a PE ratio of 10.13 and a beta of 1.41.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings data on Monday, August 4th. The company reported $5.04 EPS for the quarter, beating the consensus estimate of ($0.27) by $5.31. Semler Scientific had a return on equity of 43.84% and a net margin of 86.20%.The company had revenue of $8.22 million for the quarter, compared to analyst estimates of $8.10 million.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of SMLR. Mizuho Markets Americas LLC grew its stake in Semler Scientific by 11.8% in the third quarter. Mizuho Markets Americas LLC now owns 29,930 shares of the company’s stock worth $898,000 after purchasing an additional 3,160 shares in the last quarter. Deltec Asset Management LLC increased its holdings in Semler Scientific by 9.9% in the third quarter. Deltec Asset Management LLC now owns 110,932 shares of the company’s stock valued at $3,328,000 after buying an additional 10,000 shares during the last quarter. SG Americas Securities LLC bought a new stake in Semler Scientific in the third quarter valued at about $205,000. Generali Asset Management SPA SGR increased its holdings in Semler Scientific by 42.9% in the third quarter. Generali Asset Management SPA SGR now owns 100,000 shares of the company’s stock valued at $3,000,000 after buying an additional 30,000 shares during the last quarter. Finally, Vontobel Holding Ltd. bought a new stake in Semler Scientific in the third quarter valued at about $426,000. Institutional investors and hedge funds own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.